Although an increased age and anti‐platelet use had a borderline significance for the risk of lower GI symptoms, it is possible that both factors reflected the increased burden of co‐morbid illness commonly associated with GI symptoms [ 14 , 15 ].
← all excerpts
Frequency, Predictive Factors, and Burden of Gastrointestinal Symptoms in Patients With Type 2 Diabetes.
1
—
—